Closing the Equity Gap: An Intervention to Improve Chlamydia and Gonorrhea Testing for Adolescents and Young Adults in Primary Care

• Published in: Journal of primary care & community health Vol. 13; p. 21501319221131382
• Main Authors: Tomcho, Margaret M., Lou, Yingbo, O’Leary, Sonja C., Rinehart, Deborah J., Thomas-Gale, Tara, Penny, Lara, Frost, Holly M.
• Format: Journal Article
• Language: English
• Published: Los Angeles, CA SAGE Publications 2022; SAGE PUBLICATIONS, INC; SAGE Publishing
• Subjects: Chlamydia; Chlamydia trachomatis; Ethnicity; Gonorrhea; Health facilities; Health insurance; Infections; Intervention; Original Research; Pandemics; Pediatrics; Primary care; Quasi-experimental methods; Race; Sexually transmitted diseases; STD; Teenagers; Time series; Young adults; screening; gonorrhea; equity; chlamydia; opt-out
• ISSN: 2150-1319; 2150-1327
• DOI: 10.1177/21501319221131382

Background:
Chlamydia trachomatis and Neisseria gonorrhea are the most reported sexually transmitted infections in the United States. Testing rates remain suboptimal and may be subject to implicit bias. We evaluated the effectiveness of an opt-out chlamydia and gonorrhea testing program for adolescents and young adults in improving testing rates and promoting equity.
Methods:
An opt-out testing program that standardized testing to once annually for 14 to 24-year-old patients was implemented across 28 federally qualified health centers spanning 4 specialties. A quasi-experimental design using interrupted time series analyses evaluated testing and infection rates between baseline, intervention, and pandemic-associated test shortage periods. Reduction in testing inequities based on sex, race, ethnicity, insurance, and language preference were also examined.
Results:
A total of 57 452 encounters during the baseline, 17 320 during the intervention, and 26 993 during the test supply shortage periods were included. Testing increased from 66.8% to 81.0% (14.2% absolute increase) between baseline and intervention periods. Pediatric clinics demonstrated the largest improvement compared to other settings (absolute increase 30.9%). We found significant reductions in testing inequities for language preference (P < .001), and un-insured and public insured individuals (P < .001). More cases of chlamydia and gonorrhea were detected in the intervention period (chlamydia-29.7; gonorrhea-7.4 per 1000 patients) than in the baseline period (chlamydia-20.7; gonorrhea-4.4 per 1000 patients; P < .001).
Conclusions:
An opt-out approach increased testing, reduced inequities between some groups and detected more infections than a risk-based approach. Opt-out testing should be considered as an approach to increase detection of chlamydia and gonorrhea and promote equity.